România -
română -
ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)
fibrovein 0,2%
std pharmaceutical products limited - marea britanie - natrii tetradecil sulphat - sol inj. - 0,2% - medicatia antivaricoasa agenti de scleroza pentru injectii locale
România -
română -
ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)
fibrovein 0,5%
std pharmaceutical products limited - marea britanie - natrii tetradecil sulphat - sol inj. - 0,5% - medicatia antivaricoasa agenti de scleroza pentru injectii locale
România -
română -
ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)
fibrovein 1%
std pharmaceutical products limited - marea britanie - natrii tetradecil sulphat - sol inj. - 1% - medicatia antivaricoasa agenti de scleroza pentru injectii locale
România -
română -
ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)
fibrovein 3%
std pharmaceutical products limited - marea britanie - natrii tetradecil sulphat - sol inj. - 3% - medicatia antivaricoasa agenti de scleroza pentru injectii locale
România -
română -
ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)
fibrovein 0,2%
medipha sante - franta - natrii tetradecil sulphat - sol. inj. - 0,2% - medicatia antivaricoasa agenti de scleroza pentru injectii locale
România -
română -
ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)
fibrovein 0,5%
medipha sante - franta - natrii tetradecil sulphat - sol. inj. - 0,5% - medicatia antivaricoasa agenti de scleroza pentru injectii locale
România -
română -
ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)
fibrovein 1%
medipha sante - franta - natrii tetradecil sulphat - sol. inj. - 1% - medicatia antivaricoasa agenti de scleroza pentru injectii locale
România -
română -
ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)
fibrovein 3%
medipha sante - franta - natrii tetradecil sulphat - sol. inj. - 3% - medicatia antivaricoasa agenti de scleroza pentru injectii locale
Uniunea Europeană -
română -
EMA (European Medicines Agency)
comirnaty
biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vaccinuri - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. utilizarea acestui vaccin ar trebui să fie în conformitate cu recomandările oficiale.